About US 2017-11-15T16:06:02+00:00

Predictive Biotech’s mission is to convert cutting edge research in human biology into effective human cell and tissue products for regenerative medicine.  By working hand in hand with researchers from across the globe we are on a pathway to help rethink and reshape the future of regenerative medicine.

Provide the highest quality human cell and tissue products (HCT/P) to our physician customers and their patients.

Advances in the procurement and processing of human cell and tissue will allow Predictive Biotech to establish a strong pipeline of revolutionary Human Cell and Tissue Products (HCT/P) for regenerative medicine applications.

Predictive Biotech is a wholly owned subsidiary of Predictive Technology Group, Inc. (PRED). Predictive Technology Groups’s core focus is to revolutionize the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics. The Company has developed and/or acquired a number of proprietary technologies that open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression. PRED uses this information as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and/or treat the disease.

For more information please contact investor relations at 757-306-6090.


Predictive biotech is in the business of developing cutting edge advancements in human cell and tissue products. The data we collect in collaboration with other research institutes and our clients are the cornerstone in our product development.

Meet the team



Previously President, Sagent Technologies (medical device division of Sagent Pharmaceuticals), CEO/Co-Founder of Infusive Technologies (developer of drug delivery technologies) and Director/Co-Founder of Specialized Health Products, Inc., acquired by C.R. Bard, Inc. Mr. Robinson studied accounting at the University of Utah and received a Masters of International Management from the Thunderbird, The American Graduate School of International Management



Eric Olson is a proven leader with over 25 years of experience in every aspect of commercializing new technologies in orthopedic, spine, neurological and molecular diagnostic market segments.  He graduated from University of Utah with a bachelor of science and his masters in Hospital administration.  Eric Olson leads the company with a single minded purpose to bring better patient care through the commercialization of cutting edge bio technologies.



As a proven leader in the healthcare industry for over 23 years, Tim now serves as the President for Predictive Biotech. Playing a key role in the overall conceptualization of Predictive Biotech, he’s driving the evolution of an entirely new product, marketing and sales approach across healthcare companies, health plans and health systems.

Before bringing his talents to Predictive Biotech, Tim served as a senior executive for Fortune 100 companies UnitedHealth Group and Walgreens for 20 years, where he managed and contributed to national sales, sales operations, corporate development, product design, product packaging, market positioning, market messaging, channel conditioning and sales execution.

When he isn’t breaking new ground in the healthcare world, Tim enjoys spending his time with his family supporting Our Lady of the Lake Catholic Community, the Knights of Columbus, several youth non-profits and the American Heart Association. As a diehard alumni of St. John’s University, you’ll often see Tim sporting SJU red and campaigning tirelessly against a rival college he chooses not to acknowledge.



Dr. Schmid received his Ph.D. in Physiology from the University of Utah School of Medicine in Salt Lake City, Utah. He completed four years of post-doctoral training at the University of Utah Medical School and five years as a Research Associate at the University of Utah Medical School as a cellular biologist.  Dr. Schmid has 23 years of experience in primary cell culture, tissue processing and cryogenic storage of cells and tissues. After working at the University of Utah, from 2009 to present, Dr. Schmid has established, implemented, and supervised the operational aspects several stem cell companies, including the recovery, quality control, processing, and distribution of tissue.  He is passionate about quality and vitality of physiological products and the vast benefits they deliver.



Dr. Majors graduated from the University of Utah as a valedictorian from the School of sciences.  He received his M.D at Creighton University in 1975 and was appointed as a staff Orthopaedist at St. Mary’s Hospital – Milwaukee. In time Dr. Majors would then become the Chairman for the Department of Orthopaedic surgery at St. Mary’s, President of Blount and Schimdt spinal study group, and President of the the State Orthopaedic Society.   Dr Majors is a an exceptional physician whose knowledge and ethics are invaluable to Predictive Biotech.



A marketing and sales master for over 25 years, Michael Herbert brings his special brand of creativity and wit to the Predictive Biotech team. Driven by an entrepreneurial spirit, he specializes in business start-ups, product packaging and consumer experience.

Michael’s previous experience includes ownership and leadership positions with some of the consumer sporting goods channels most revered brands. Creating and driving the global marketing, brand strategy and sales effectively drove Bianchi bicycles, Castelli apparel and Shock Doctor to the top position in their category and markets.

Herbert helps our clients craft internal /external messaging, marketing structure and rollout and product positioning.

Michael spends plenty of time outdoors, whether cycling, fly fishing or skiing. He serves on two non-profit boards, and is active in the community.



A St. Louis native and a New York transplant, Kevin Johnston has been bringing healthcare solutions to life for more than 15 years. He works to develop new client partnerships, provide distinctive sales execution services and shakes an incredible amount of healthplan hands throughout the year. His breadth of expertise, transaction and industry experience contributes to Predictive Biotech’s ability to structure, finance, and manage successful enterprise sales.

Prior to his role in Healthplan Strategies, Kevin served as an executive with Emdeon and lead sales at RedCard Systems, both healthcare technology and business process companies. At this point, his middle name may very well be “Collaboration.”

Kevin is an avid soccer fan and former professional player, who proudly holds a spot in St. Louis University’s Athletic Hall of Fame. He enjoys spending time with his wife Kathy enjoying exploring the fine arts and fine restaurants of New York City.